Furthermore, recent research investigating MC-tumor cell interaction-related genes and microRNA expression profiles underscores the clinical relevance of CCL2 signaling and the differential expression of the CCL2/CCR2 axis in OSCC (86). This evidence concerns the gene CCL2 and neoplasm.